Respiratory · Respiratory — Fabry disease
Tazoti 500 mg
Fluticasone
Respiratory Cleared
Tazoti 500 mg
Fluticasone
Dosage form
Prolonged-release tablet
Pack size
56 tablets / blister
Manufacturer
Ionira Pharma
SKU
TAB-TAZ-3027
CAS #
5202-66-3
ATC code
N0570A
NDC
4979-769-73
Status
approved
Indication
Respiratory — Fabry disease
Compliance
Sourced from licensed manufacturers with full chain-of-custody. WHO-GSDP and EU GDP compliant. Batch records, certificates of analysis and audit documentation supplied on request for institutional orders.
Talk to a pharmacist
A licensed pharmacist will respond within 18 business hours.
Related brands
Same molecule or therapeutic area.
